• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性子宫切除术加同步放化疗/放疗与宫颈癌患者恢复工作呈负相关。

Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer.

作者信息

Nakamura Keiichiro, Masuyama Hisashi, Ida Naoyuki, Haruma Tomoko, Kusumoto Tomoyuki, Seki Noriko, Hiramatsu Yuji

机构信息

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

出版信息

Int J Gynecol Cancer. 2017 Jan;27(1):117-122. doi: 10.1097/IGC.0000000000000840.

DOI:10.1097/IGC.0000000000000840
PMID:27668396
Abstract

OBJECTIVE

Cervical cancer is one of the most common malignant diseases in working-age women. This study investigated the influence of adverse effects of various treatment modalities on return to work in women with cervical cancer.

METHODS

Questionnaires and clinical data from medical records of 97 patients with early stage (stages I and II) cervical cancer were collected and assessed by treatment received. The following treatment groups were analyzed for correlations between time to return to work and various adverse effects: radical hysterectomy (RH) alone, RH group (n = 29); concurrent chemoradiation therapy (CCRT)/radiation therapy (RT) alone, CCRT/RT group (n = 21); and RH + CCRT/RT group (n = 47). The χ test was used to determine the significance of the correlations.

RESULTS

The mean age at the time of diagnosis was 43.0 years and the average interval since treatment was 4.5 years. The RH + CCRT/RT group was the most strongly negatively associated with return to work in employed patients who had undergone CCRT/RT group of cervical cancer (P = 0.012). There was a significant association between failure to return to work and lower extremity lymphedema (P = 0.049). A more than-6-month interval between treatment and return to work and reduced personal income occurred in a significantly higher percentage of patients in the RH + CCRT group than in the CCRT/RT group (P = 0.034 and P = 0.034).

CONCLUSIONS

Of the treatments assessed, RH + CCRT/RT has the greatest negative effect on return to work in women with cervical cancer.

摘要

目的

宫颈癌是育龄期女性最常见的恶性疾病之一。本研究调查了各种治疗方式的不良反应对宫颈癌患者恢复工作的影响。

方法

收集97例早期(I期和II期)宫颈癌患者的问卷及病历临床资料,并根据接受的治疗进行评估。分析以下治疗组恢复工作时间与各种不良反应之间的相关性:单纯根治性子宫切除术(RH),RH组(n = 29);同步放化疗(CCRT)/单纯放疗(RT),CCRT/RT组(n = 21);以及RH + CCRT/RT组(n = 47)。采用χ检验确定相关性的显著性。

结果

诊断时的平均年龄为43.0岁,治疗后的平均间隔时间为4.5年。在接受过CCRT/RT的在职宫颈癌患者中,RH + CCRT/RT组与恢复工作的负相关性最强(P = 0.012)。未能恢复工作与下肢淋巴水肿之间存在显著关联(P = 0.049)。与CCRT/RT组相比,RH + CCRT组中治疗至恢复工作间隔超过6个月以及个人收入减少的患者比例显著更高(P = 0.034和P = 0.034)。

结论

在所评估的治疗方式中,RH + CCRT/RT对宫颈癌患者恢复工作的负面影响最大。

相似文献

1
Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer.根治性子宫切除术加同步放化疗/放疗与宫颈癌患者恢复工作呈负相关。
Int J Gynecol Cancer. 2017 Jan;27(1):117-122. doi: 10.1097/IGC.0000000000000840.
2
Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial.子宫切除术辅助治疗宫颈癌的序贯放化疗与同期放化疗或单纯放疗的疗效比较:STARS 三期随机临床试验。
JAMA Oncol. 2021 Mar 1;7(3):361-369. doi: 10.1001/jamaoncol.2020.7168.
3
Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.早期宫颈癌患者无高危因素行根治术后单纯放疗与辅助同步放化疗的疗效比较。
BMC Cancer. 2024 Apr 30;24(1):548. doi: 10.1186/s12885-024-12284-9.
4
Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion.IIICr期无宫旁浸润宫颈癌根治性子宫切除术与同步放化疗的肿瘤学结局及并发症发生率比较
BMC Cancer. 2025 Apr 30;25(1):811. doi: 10.1186/s12885-025-14196-8.
5
Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.根治性子宫切除术后中危宫颈癌患者接受拓扑替康和顺铂放疗或放化疗的随机 III 期试验。
BMC Cancer. 2015 May 4;15:353. doi: 10.1186/s12885-015-1355-1.
6
[Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].[术后同步放化疗对具有中危因素的早期宫颈癌患者的疗效分析]
Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):462-466. doi: 10.3760/cma.j.issn.0253-3766.2018.06.012.
7
Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO 2018) with one intermediate-risk factor: a multicentre retrospective cohort study of 63,926 cases.对具有一个中危因素的IA-IIA期宫颈腺癌(国际妇产科联盟2018年分期)的术后辅助治疗:一项对63926例病例的多中心回顾性队列研究
World J Surg Oncol. 2025 Mar 14;23(1):87. doi: 10.1186/s12957-025-03739-9.
8
Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).FIGO IB1期宫颈癌且具有中度危险因素患者根治性子宫切除术后辅助放疗对结局和并发症影响的分析(GOTIC研究)
World J Surg Oncol. 2016 Jun 29;14(1):173. doi: 10.1186/s12957-016-0931-4.
9
Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.根治性子宫切除术及辅助放疗或放化疗治疗宫颈腺癌或腺鳞癌的临床行为和结局。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):420-7. doi: 10.1016/j.ijrobp.2011.12.013. Epub 2012 Feb 24.
10
Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.国际妇产科联盟(FIGO)分期为IB-IIA期宫颈癌且磁共振成像显示宫颈基质环局灶性中断患者的治疗结局:一项倾向评分匹配研究
Gynecol Oncol. 2016 Oct;143(1):77-82. doi: 10.1016/j.ygyno.2016.07.102. Epub 2016 Jul 15.

引用本文的文献

1
A 5-year prospective assessment of risk factors for lower limb lymphedema after gynecologic cancer surgery.一项对妇科癌症手术后下肢淋巴水肿危险因素的5年前瞻性评估。
Sci Rep. 2025 Jul 21;15(1):26371. doi: 10.1038/s41598-025-11732-1.
2
Exercise interventions for the treatment of lower limb lymphoedema after treatment for gynaecological cancers.妇科癌症治疗后下肢淋巴水肿治疗的运动干预措施
Cochrane Database Syst Rev. 2025 Jun 3;6(6):CD015669. doi: 10.1002/14651858.CD015669.
3
Effectiveness of isometric muscle training combined with manual lymphatic drainage on secondary lower extremity lymphedema following gynecologic cancer surgery.
等长肌肉训练联合手法淋巴引流对妇科癌症手术后继发性下肢淋巴水肿的疗效
Front Bioeng Biotechnol. 2025 May 14;13:1568003. doi: 10.3389/fbioe.2025.1568003. eCollection 2025.
4
Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer.盆腔妇科癌症根治性放疗和放化疗后的重返工作、疲劳与癌症康复
Cancers (Basel). 2022 May 8;14(9):2330. doi: 10.3390/cancers14092330.
5
Employment disruption among women with gynecologic cancers.妇科癌症女性的就业中断。
Int J Gynecol Cancer. 2022 Jan;32(1):69-78. doi: 10.1136/ijgc-2021-002949. Epub 2021 Nov 16.
6
The Fact of Return to Work in Cervical Cancer Survivors and the Impact of Survival Rate: An 11-Year Follow-Up Study.宫颈癌幸存者的工作回归事实和生存率的影响:一项 11 年随访研究。
Int J Environ Res Public Health. 2021 Oct 12;18(20):10703. doi: 10.3390/ijerph182010703.
7
Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer.miR-29b 的治疗性递送增强宫颈癌的放射敏感性。
Mol Ther. 2019 Jun 5;27(6):1183-1194. doi: 10.1016/j.ymthe.2019.03.020. Epub 2019 Apr 11.